166 related articles for article (PubMed ID: 2556240)
1. Efficacy of fluconazole in cryptococcal meningitis.
Jones PD; Marriott D; Speed BR
Diagn Microbiol Infect Dis; 1989; 12(4 Suppl):235S-238S. PubMed ID: 2556240
[TBL] [Abstract][Full Text] [Related]
2. Fluconazole compared with amphotericin B plus flucytosine for cryptococcal meningitis in AIDS. A randomized trial.
Larsen RA; Leal MA; Chan LS
Ann Intern Med; 1990 Aug; 113(3):183-7. PubMed ID: 2197908
[TBL] [Abstract][Full Text] [Related]
3. [Clinical and therapeutic profile of 3 cases of cryptococcal meningitis in patients with AIDS].
Michelone G; Tacconi F; Maccabruni A; Lanzarini P; Tinelli M; Dei Cas A
G Ital Chemioter; 1989; 36(1-3):95-9. PubMed ID: 2562240
[TBL] [Abstract][Full Text] [Related]
4. A placebo-controlled trial of maintenance therapy with fluconazole after treatment of cryptococcal meningitis in the acquired immunodeficiency syndrome. California Collaborative Treatment Group.
Bozzette SA; Larsen RA; Chiu J; Leal MA; Jacobsen J; Rothman P; Robinson P; Gilbert G; McCutchan JA; Tilles J
N Engl J Med; 1991 Feb; 324(9):580-4. PubMed ID: 1992319
[TBL] [Abstract][Full Text] [Related]
5. Oral fluconazole therapy for patients with acquired immunodeficiency syndrome and cryptococcosis: experience with 22 patients.
Stern JJ; Hartman BJ; Sharkey P; Rowland V; Squires KE; Murray HW; Graybill JR
Am J Med; 1988 Oct; 85(4):477-80. PubMed ID: 2845778
[TBL] [Abstract][Full Text] [Related]
6. Parenteral and oral fluconazole for acute cryptococcal meningitis in AIDS: experience with thirteen patients.
Stern JJ; Pietroski NA; Buckley RM; Braffman MN; Rinaldi MG
Ann Pharmacother; 1992; 26(7-8):876-82. PubMed ID: 1504391
[TBL] [Abstract][Full Text] [Related]
7. Oral fluconazole as suppressive therapy of disseminated cryptococcosis in patients with acquired immunodeficiency syndrome.
Sugar AM; Saunders C
Am J Med; 1988 Oct; 85(4):481-9. PubMed ID: 2845779
[TBL] [Abstract][Full Text] [Related]
8. Overview: treatment of cryptococcal meningitis.
Sugar AM; Stern JJ; Dupont B
Rev Infect Dis; 1990; 12 Suppl 3():S338-48. PubMed ID: 2184512
[TBL] [Abstract][Full Text] [Related]
9. Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group.
van der Horst CM; Saag MS; Cloud GA; Hamill RJ; Graybill JR; Sobel JD; Johnson PC; Tuazon CU; Kerkering T; Moskovitz BL; Powderly WG; Dismukes WE
N Engl J Med; 1997 Jul; 337(1):15-21. PubMed ID: 9203426
[TBL] [Abstract][Full Text] [Related]
10. Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. The NIAID Mycoses Study Group and the AIDS Clinical Trials Group.
Saag MS; Powderly WG; Cloud GA; Robinson P; Grieco MH; Sharkey PK; Thompson SE; Sugar AM; Tuazon CU; Fisher JF
N Engl J Med; 1992 Jan; 326(2):83-9. PubMed ID: 1727236
[TBL] [Abstract][Full Text] [Related]
11. Amphotericin B with or without flucytosine followed by fluconazole as primary therapy for cryptococcal meningitis in patients with AIDS.
Jaruratanasirikul S
Southeast Asian J Trop Med Public Health; 1996 Dec; 27(4):719-23. PubMed ID: 9253873
[TBL] [Abstract][Full Text] [Related]
12. Profound papilledema due to cryptococcal meningitis in acquired immunodeficiency syndrome: successful treatment with fluconazole.
Good CB; Leeper HF
South Med J; 1991 Mar; 84(3):394-6. PubMed ID: 2000533
[TBL] [Abstract][Full Text] [Related]
13. A controlled trial of fluconazole or amphotericin B to prevent relapse of cryptococcal meningitis in patients with the acquired immunodeficiency syndrome. The NIAID AIDS Clinical Trials Group and Mycoses Study Group.
Powderly WG; Saag MS; Cloud GA; Robinson P; Meyer RD; Jacobson JM; Graybill JR; Sugar AM; McAuliffe VJ; Follansbee SE
N Engl J Med; 1992 Mar; 326(12):793-8. PubMed ID: 1538722
[TBL] [Abstract][Full Text] [Related]
14. Cryptococcal meningitis in the acquired immunodeficiency syndrome.
Panther LA; Sande MA
Semin Respir Infect; 1990 Jun; 5(2):138-45. PubMed ID: 2247708
[TBL] [Abstract][Full Text] [Related]
15. Cost implications of alternative treatments for AIDS patients with cryptococcal meningitis. Comparison of fluconazole and amphotericin B-based therapies.
Buxton MJ; Dubois DJ; Turner RR; Sculpher MJ; Robinson PA; Searcy C
J Infect; 1991 Jul; 23(1):17-31. PubMed ID: 1885910
[TBL] [Abstract][Full Text] [Related]
16. Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America.
Saag MS; Graybill RJ; Larsen RA; Pappas PG; Perfect JR; Powderly WG; Sobel JD; Dismukes WE
Clin Infect Dis; 2000 Apr; 30(4):710-8. PubMed ID: 10770733
[TBL] [Abstract][Full Text] [Related]
17. Cryptococcal infection in AIDS.
Coker RJ
Int J STD AIDS; 1992; 3(3):168-72. PubMed ID: 1616962
[TBL] [Abstract][Full Text] [Related]
18. The efficacy of fluconazole 600 mg/day versus itraconazole 600 mg/day as consolidation therapy of cryptococcal meningitis in AIDS patients.
Mootsikapun P; Chetchotisakd P; Anunnatsiri S; Choksawadphinyo K
J Med Assoc Thai; 2003 Apr; 86(4):293-8. PubMed ID: 12757072
[TBL] [Abstract][Full Text] [Related]
19. Therapy for cryptococcal meningitis in patients with AIDS.
Powderly WG
Clin Infect Dis; 1992 Mar; 14 Suppl 1():S54-9. PubMed ID: 1562696
[TBL] [Abstract][Full Text] [Related]
20. High-dose fluconazole for treatment of cryptococcal disease in patients with human immunodeficiency virus infection. The California Collaborative Treatment Group.
Haubrich RH; Haghighat D; Bozzette SA; Tilles J; McCutchan JA
J Infect Dis; 1994 Jul; 170(1):238-42. PubMed ID: 8014509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
